
The Middle-East and Africa Clinical trial imaging Market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Clinical trial is major process in drug development process. Drug development process is expensive and need huge funding. Imaging perform different functions in clinical trials like detection, characterization, and monitoring or assessment. Pharmaceutical and biotechnology companies investing in R&D to develop new drugs which further observed and make available to the public. Imaging also plays important role to minimize the cost of clinical trials. Imaging is a natural fit for early phase trials, since they are more dynamic and involve more scientific work than later-phase trials. Imaging biomarkers to increase the probability of success in clinical trials and to evaluate efficacy more rapidly. Increasing number of non-communicable diseases, improved healthcare infrastructure, and government initiatives are leading the growth for clinical trial imaging market in Middle East and Africa. However, there are some factors affecting the growth for clinical trial imaging market in Middle East and Africa such as inaccurate data collection, improper data sharing, expensive drug development process, limited access to the advance imaging technology, delays in trial, strict government regulations etc.